Skip to main content
SpringerLink
Log in

Rifampicin sparing treatment protocols in posttransplant tuberculosis

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chugh KS, Jha V. Tuberculosis following organ transplantation. Transplantation Proc 2003; 35: 2676–2677.

    Article  CAS  Google Scholar 

  2. Vachharajani TJ, Oza UG, Phadke AG, Kirpalani AL. Tuberculosis in renal transplant recipients: rifampicin sparing treatment protocol. Int Urol Nephrol 2002; 34: 551–553.

    Article  PubMed  CAS  Google Scholar 

  3. Sakhuja V, Jha V, Varma PP, Joshi K, Chugh KS. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation 1996; 61: 211–215.

    Article  PubMed  CAS  Google Scholar 

  4. Jha V, Sakhuja V, Gupta D et al. Successful management of pulmonary tuberculosis in renal allograft recipients in a single center. Kidney Int 1999; 56: 1944–1950.

    Article  PubMed  CAS  Google Scholar 

  5. Hu Y, Coates AR, Mitchison DA. Sterilizing Activities of Fluoroquinolones against Rifampin-Tolerant Populations of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2003; 47: 653–657.

    Article  PubMed  CAS  Google Scholar 

  6. Rastogi N, Labrousse V, Goh KS. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Curr Microbiol 1996; 33: 167–175.

    Article  PubMed  CAS  Google Scholar 

  7. Tomioka H, Sato K, Shimizu T, Sano C. Anti-Mycobacterium tuberculosis activities of new fluoroquinolones in combination with other antituberculous drugs. J Infect 2002; 44: 160–165.

    Article  PubMed  CAS  Google Scholar 

  8. Ginsburg AS, Grosset JH, Bishai WR. Fluoroquinolones, tuberculosis, and resistance. Lancet Infect Dis 2003; 3: 432–442.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

    Vivekanand Jha & Vinay Sakhuja

Authors
  1. Vivekanand Jha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vinay Sakhuja
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vivekanand Jha.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jha, V., Sakhuja, V. Rifampicin sparing treatment protocols in posttransplant tuberculosis. Int Urol Nephrol 36, 287–288 (2004). https://doi.org/10.1023/B:UROL.0000034616.17935.98

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:UROL.0000034616.17935.98

Search

Navigation